Matthew R Teater

13PUBLICATIONS
118CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Evolution of developmental systemsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 21, 2026
SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilities.

|Jan 19, 2023
<i>BTG1</i> mutation yields supercompetitive B cells primed for malignant transformation.

Coraline Mlynarczyk, Matt Teater, Juhee Pae

|Oct 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.

Leandro Venturutti, Martin A Rivas, Benedikt W Pelzer

|Jun 03, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.

Min Xia, Liron David, Matt Teater

|Apr 20, 2022
SETD2 Haploinsufficiency Enhances Germinal Center-Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis.

Wilfred Leung, Matt Teater, Ceyda Durmaz

|Jan 12, 2022
Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival.

Meng Li, Matthew R Teater, Jun Young Hong

Pageof 3

Frequent Collaborators

8 joint publications

Ari Melnick

6 joint publications

Cem Meydan

4 joint publications

Lorena Fontán

4 joint publications

Martín A Rivas